RASTETTER WILLIAM H

CIK 00012059037 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001205903

Recent Transactions

50 trades

Award
Dare Bioscience, Inc.$DARE
Common stock
2026-06-30+38,862→ 39,721 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2026-06-12+87,900→ 87,900 total
Award
Dare Bioscience, Inc.$DARE
Stock Option (right to buy)
2026-06-11+10,000→ 10,000 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restriced Stock Unit
2026-05-27+2,567→ 2,567 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2026-05-21−3,318→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-05-21+3,318→ 43,678 total
Exercise/Conversion
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2026-05-05+25,000→ 0 total
Exercise/Conversion
FATE THERAPEUTICS INC$FATE
Common Stock
2026-05-05$1.69/sh+25,000→ 36,331 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-11-05$47.89/sh+18,000→ 58,360 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2025-11-05−18,000→ 0 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-11-05$151.82/sh−18,000→ 40,360 total
Award
Dare Bioscience, Inc.$DARE
Stock Option (right to buy)
2025-07-09+4,500→ 4,500 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−4,650→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−15,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−9,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−30,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−60,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−30,000→ 0 total
Disposition from Tender
Regulus Therapeutics Inc.
Common Stock
2025-06-25−44,264→ 57,292 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−4,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−2,325→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Common Stock
2025-06-25−57,292→ 0 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2025-05-29+55,000→ 55,000 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-05-22+2,869→ 40,360 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-05-22−2,869→ 0 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-05-21+3,318→ 3,318 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-05-05$110.20/sh−30,000→ 37,491 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-05-05$42.76/sh+30,000→ 67,491 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2025-05-05−30,000→ 0 total
Award
Regulus Therapeutics Inc.
Common Stock
2025-04-30+62,500→ 101,556 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-08-15$146.69/sh−14,250→ 37,491 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2024-06-07+40,000→ 40,000 total
Award
Dare Bioscience, Inc.$DARE
Stock Option (right to buy)
2024-06-05+40,000→ 40,000 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2024-05-22+2,869→ 2,869 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2024-05-20+60,000→ 60,000 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2024-05-16+30,000→ 30,000 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-01-02$131.47/sh−11,044→ 51,741 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-01-02$12.98/sh−20,000→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-01-02$12.98/sh+20,000→ 62,785 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2023-08-10+15,000→ 15,000 total
Award
Dare Bioscience, Inc.$DARE
Stock Option (right to buy)
2023-06-21+40,000→ 40,000 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2023-06-13+30,000→ 30,000 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2023-06-06+40,000→ 40,000 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2023-05-17+8,579→ 8,579 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-05-01$101.43/sh−4,300→ 42,785 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2023-05-01$12.71/sh−7,625→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-05-01$12.71/sh+7,625→ 47,085 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2023-04-21$12.71/sh−10,765→ 7,625 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-04-21$105.04/sh−6,034→ 39,460 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-04-21$12.71/sh+10,765→ 45,494 total

Companies

Recent Filings

Address

3655 NOBEL DRIVE SUITE 260

SAN DIEGO, CA, 92122

View on SEC.gov